Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs
- PMID: 10376022
Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs
Abstract
Objective: Exploration of longer-term outcomes of an ongoing educational-outreach service for community doctors.
Design: Quasi-experimental, with parallel and historical comparisons.
Setting: Since 1992, a teaching-hospital-based service has been providing advice and information on drugs and therapeutic strategies to community medical practitioners.
Participants: 210 doctors practising in a particular area of metropolitan Adelaide (79% general practitioners; 21% specialists).
Interventions: Two surgery visits during 1992 focused on better use of prescribed non-steroidal anti-inflammatory drugs (NSAIDs). Subsequent visits on other topical therapeutic issues have occurred regularly.
Main outcome measures: Doctor participation in the service; supply of prescription NSAIDs; hospital admissions for gastrointestinal (GI) effects of NSAID use.
Results: 89% of doctors practising within the service area received the first visit on NSAIDs and 86% received the second visit. More than 85% continue to receive the service. Relative to a comparison area, aggregate reductions of 9% and 28%, respectively, were observed in two different measures of NSAID use. During an 11-year observation period, a single change point in the number of hospital admissions for GI disorders occurred in the service area, coinciding with delivery of the NSAID program. In the five years since the visits commenced, a 70% reduction in admissions was observed. No notable changes in hospital admission rates occurred in the comparison area.
Conclusions: A continuing education and support service for community medical practitioners which uses principally academic detailing methods in its contact with doctors has contributed to sustained changes in prescribed NSAID use over a five-year period. A focus on risk-minimisation in prescribing of NSAIDs appears to have contributed to reductions in hospitalisations for GI adverse events.
Comment in
-
Pharmacists' outreach visits and doctors' prescribing.Med J Aust. 1999 May 17;170(10):460-1. doi: 10.5694/j.1326-5377.1999.tb127841.x. Med J Aust. 1999. PMID: 10376017 No abstract available.
-
Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs.Med J Aust. 1999 Oct 4;171(7):388-9. Med J Aust. 1999. PMID: 10590733 No abstract available.
Similar articles
-
Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France.Pharmacoepidemiol Drug Saf. 2001 Jun-Jul;10(4):329-38. doi: 10.1002/pds.623. Pharmacoepidemiol Drug Saf. 2001. PMID: 11760495
-
Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.Rheumatology (Oxford). 2005 Oct;44(10):1308-10. doi: 10.1093/rheumatology/kei016. Epub 2005 Jun 21. Rheumatology (Oxford). 2005. PMID: 15972345
-
Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.Am J Manag Care. 2004 Nov;10(11 Pt 1):742-50. Am J Manag Care. 2004. PMID: 15623264
-
[NSAID--non-steroidal anti-inflammatory agents. Used too much? Which preparations should we choose? Damage of the cartilage?].Ugeskr Laeger. 1998 May 18;160(21):3097-100. Ugeskr Laeger. 1998. PMID: 9621792 Review. Danish. No abstract available.
-
Is there scope for improving the cost-effective prescribing of nonsteroidal anti-inflammatory drugs?Pharmacoeconomics. 1996 Jun;9(6):484-96. doi: 10.2165/00019053-199609060-00003. Pharmacoeconomics. 1996. PMID: 10160476 Review.
Cited by
-
Description and process evaluation of pharmacists' interventions in a pharmacist-led information technology-enabled multicentre cluster randomised controlled trial for reducing medication errors in general practice (PINCER trial).Int J Pharm Pract. 2014 Feb;22(1):59-68. doi: 10.1111/ijpp.12039. Epub 2013 May 30. Int J Pharm Pract. 2014. PMID: 23718905 Free PMC article. Clinical Trial.
-
Safer medicines management in primary care.Br J Gen Pract. 2002 Oct;52 Suppl(Suppl):S17-22. Br J Gen Pract. 2002. PMID: 12389765 Free PMC article.
-
Communication of medical product risk: how effective is effective enough?Drug Saf. 2004;27(8):519-34. doi: 10.2165/00002018-200427080-00005. Drug Saf. 2004. PMID: 15154825 Review.
-
Adverse drug reactions to antiretroviral therapy: prospective study in children in sikasso (mali).J Pediatr Pharmacol Ther. 2012 Oct;17(4):382-8. doi: 10.5863/1551-6776-17.4.382. J Pediatr Pharmacol Ther. 2012. PMID: 23411444 Free PMC article.
-
Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.BMC Fam Pract. 2020 May 9;21(1):85. doi: 10.1186/s12875-020-01158-1. BMC Fam Pract. 2020. PMID: 32386520 Free PMC article.